abstract |
The present invention relates to the treatment of diseases that can be modulated by local increases in extracellular adenosine. An analog of 5-amino-1-β-D-ribofuranosylimidazole-4-carboxamide (AICA riboside) useful in increasing extracellular levels of adenosine is provided. [Selection figure] None |